3-Pyridinecarboxylic acid, (2E)-2-[[4-[[(4-methylphenyl)amino]carbonyl]phenyl]methylene]hydrazide manufacturers
|
| | 3-Pyridinecarboxylic acid, (2E)-2-[[4-[[(4-methylphenyl)amino]carbonyl]phenyl]methylene]hydrazide Basic information |
| | 3-Pyridinecarboxylic acid, (2E)-2-[[4-[[(4-methylphenyl)amino]carbonyl]phenyl]methylene]hydrazide Chemical Properties |
| density | 1.20±0.1 g/cm3(Predicted) | | pka | 11.07±0.46(Predicted) |
| | 3-Pyridinecarboxylic acid, (2E)-2-[[4-[[(4-methylphenyl)amino]carbonyl]phenyl]methylene]hydrazide Usage And Synthesis |
| Uses | Antitumor agent-70 (compound 8b) has anti-tumor activity and can induce cell apoptosis. Antitumor agent-70 inhibits multiple myeloma with an IC50 value of 0.12 μM. Antitumor agent-70 is a potential multi-targeted kinase inhibitor especially for c-Kit[1]. | | References | [1] Xin-Yang Li, et al. Design, synthesis and biological evaluation of novel (E)-N-phenyl-4-(pyridine-acylhydrazone) benzamide derivatives as potential antitumor agents for the treatment of multiple myeloma (MM). Bioorg Chem. 2020 Oct;103:104189. DOI:10.1016/j.bioorg.2020.104189 |
| | 3-Pyridinecarboxylic acid, (2E)-2-[[4-[[(4-methylphenyl)amino]carbonyl]phenyl]methylene]hydrazide Preparation Products And Raw materials |
|